Trio Holdings PLC
24 January 2005
Trio Holdings Plc ('Trio' or the 'Company')
Following the recent movement in the Company's ordinary share price Trio
announces that it is in discussions with a Private Equity consortium, including
certain members of the management of Trio's subsidiaries, which may or may not
lead to an offer being made for the Company's entire issued and to be issued
share capital at a price of 32 pence in cash per Trio ordinary share. Trio
shareholders should note that disclosure of the price at which this indicative
offer has been made has been disclosed solely at the instigation of the
directors of Trio. Given that discussions are at a preliminary stage, there can
be no assurance that a formal offer will be announced at this price, or at all.
Further announcements will be made as appropriate in due course.
Pursuant to Rule 2.10 of the City Code on Takeovers and Mergers, Trio announces
that it has 83,484,325 ordinary shares in issue (ISIN: GB0008946781).
Enquiries
David Hagan, Trio Holdings PLC 020 7946 9100
Jonathan Hinton/David Kent, Deloitte 020 7936 3000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.